BALTIMORE (Stockpickr) -- Put down the 10-K filings and the stock screeners. It's time to take a break from the traditional methods of generating investment ideas. Instead, let the crowd do it for you.

From hedge funds to individual investors, scores of market participants are turning to social media to figure out which stocks are worth watching. It's a concept that's known as "crowdsourcing," and it uses the masses to identify emerging trends in the market.

Crowdsourcing has long been a popular tool for the advertising industry, but it also makes a lot of sense as an investment tool. After all, the market is completely driven by the supply and demand, so it can be valuable to see what names are trending among the crowd.

While some fund managers are already trying to leverage social media resources like Twitter to find algorithmic trading opportunities, for most investors, crowdsourcing works best as a starting point for investors who want a starting point in their analysis.

Today, we'll leverage the power of the crowd to take a look at some of the most active stocks on the market today.

CTI BioPharma

Nearest Resistance: $3
Nearest Support: $2.50
Catalyst: Positive Drug Data

Small-cap biopharmaceutical stock CTI BioPharma (CTIC) - Get Report didn't let its small size get in the way of being one of the most heavily traded issues on the Nasdaq on Monday. Shares rallied 6.4% thanks to bullish data to start the week. The firm announced with partner Baxter International (BAX) that it had gotten favorable phase 3 results from its myleofybrosis treatment, pacritinib. The possibility of seeing commercialization of the marrow cancer treatment spurred the buying yesterday, but the wheels were actually set in motion last week.

That's because CTIC broke through key resistance at $2.50 last week, clearing the way for a test of new highs. While buyers are clearly in control now, the event risk surrounding this stock are significant. Only experienced traders should try their hands at this stock.

Rite Aid

Nearest Resistance: $8.50
Nearest Support: $7.50
Catalyst: February Sales

Rite Aid (RAD) - Get Report is testing a key support level this morning, a carryover from the drug store chain's weak same store sales release last Thursday. RAD has corrected 6.7% since its sales numbers were released, but support remains intact here.

Shares have actually been in an uptrend going back to the middle of October, catching a bid at every successive test of support along the way. It's early to call RAD buyable, but any sign of a bounce off of support this week makes a good entry opportunity. Just keep a tight stop in place if you decide to buy the bounce.

Whiting Petroleum

Nearest Resistance: $40
Nearest Support: $33
Catalyst: Potential Sale

Shares of Whiting Petroleum (WLL) - Get Report bucked the trend of commodity stocks dropping yesterday, instead rallying 10.8% during Monday's session. The catalyst was a rumor that WLL is hiring an investment bank to help it pursue a possible sale of the $5.7 billion company. The public markets have been brutal to WLL, slashing this firm's market value by 60% since September, and management may be looking for a more lucrative exit opportunity.

Ironically, WLL is starting to look "bottomy" thanks to the sale rumors. Resistance at $40 is the breakout level to watch in Whiting. If $40 gets taken out, then we've got a buy signal in this long-suffering oil and gas producer.

BlackBerry

Nearest Resistance: $11.50
Nearest Support: $9.75
Catalyst: Analyst Note

Finally, troubled handset maker BlackBerry (BBRY) started the week off on a sour note, dropping 7.5% on a negative analyst note from Goldman Sachs. Goldman cut BlackBerry's price target to $9, citing widening losses as a cause for concern coming up. But while BBRY corrected pretty hard, the technical picture hasn't changed in this stock -- at least not yet.

Shares have been consolidating in a relatively narrow range since last summer, and uptrending support is being tested this week. As long as shares end up higher, BBRY still has a shot at a breakout up at $11.50. Earnings at the end of the month could be the catalyst they need. Otherwise, a violation of $9.75 support is a sell signal.

At the time of publication, author had no positions in stocks mentioned.